Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
36.37 USD -6.72% Intraday chart for Apogee Therapeutics, Inc. -17.92% +30.17%
05-28 Apogee Therapeutics, Inc. Appoints Lisa Bollinger to Its Board of Directors CI
05-15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
8182308f40fb9f6af89d6.FH5tMz2AVCtrFOCWMhmOD3H3csiu1lQcE1c9VPUAd9c.ekYaYwrWYBgndtDnairbSRmVQKHat2Z6YQgIZNhCQ6RiR1RibfEBWykhgw~ec2f770e70d6d8032d987bd74c71cc0d
  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Charts Apogee Therapeutics, Inc.
  5. News Chart